Subacute invasive pulmonary aspergillosis following breast cancer treatment: A one-year diagnostic odyssey

This case illustrates the prolonged diagnostic odyssey characteristic of SIPA in cancer survivors and emphasises the critical importance of maintaining clinical suspicion for invasive fungal infections beyond the immediate post-chemotherapy period. Molecular diagnostics combined with Aspergillus-specific serology proved superior to conventional methods, whilst serial antibody monitoring provided valuable biomarker-guided treatment assessment. Early recognition and appropriate antifungal therapy can achieve excellent outcomes even after protracted symptomatic periods.